[one_third]
[/one_third]
[one_third]
[/one_third]
[one_third_last]
[/one_third_last]
[wpdatatable id=105]
[one_third]
[/one_third]
[two_third_last]
Lab, vendor views on instruments, assays, and data
Instruments, assays, patient flow, and IT were some of what laboratory directors and IVD company representatives spoke of when CAP TODAY publisher Bob McGonnagle convened the group online on May 3. Here’s what they said about what instruments and assays are deployed where and the considerations that come into play in large health systems.
CAP TODAY’s guide to chemistry and immunoassay analyzers for mid- and high-volume laboratories begins here. The guide to analyzers for use at the point of care and in low-volume labs, in the June issue, is at https://bit.ly/CT_0624-PG.
During last year’s roundtable on chemistry and immunoassay systems, there was an emphasis on labs needing to be agile and adaptive and to know they might be a hub or a spoke in this environment of consolidation. Being nimble and flexible is important to being able to grow and scale, particularly being able to deploy instruments as conditions dictate.
Ryan Stephens, talk to us about the aging population, which has deep significance for the workforce and the patient population you’ll be testing, and consolidation. How do you see it coming?
Ryan Stephens, group marketing manager, automation and core lab digital solutions, Roche: One challenge with an aging population is access. How do you ensure access to laboratory medicine for this population, especially in rural areas where the draw station or closest lab might be a couple of hours away and they might not have reliable transportation. How do we work with new services that are coming out with at-home testing or sampling and integrate it into our testing practice? How do we provide access as staffing becomes more difficult? As the population ages, monitoring them with laboratory diagnostics will be increasingly important so you can get them the right therapies and treatments and help improve their health, which will ultimately reduce the overall cost of health care in the U.S.
Continue reading …
[/two_third_last]